China News Service, December 21 (Reporter Chen Jing) Professor Wu Depei, chairman of the Hematology Branch of the Chinese Medical Association, told reporters on the 21st that China Stem Cell Group has completed more than 5,100 stem cell transplants so far through long-term accumulation and hard work. Both indicators and achievements lead the world, saving patients and families with blood diseases.
The Hematology Branch of the Chinese Medical Association will integrate the resources of the society, help the construction of the group's affiliated hospitals and the departments of hematology in various regions, and promote the advancement and transformation of stem cell medical technology.
The Shanghai Cord Blood Bank of China Stem Cell Group grew out of nothing and has experienced 20 years of development.
Photo courtesy of China Stem Cell Group
The reporter learned on the 21st that the "16th China Cord Blood Stem Cell Transplantation and Ethics Conference" focused on the development direction and ethical compliance requirements of stem cell transplantation, and looked forward to the future application prospects and unlimited opportunities of the stem cell industry.
Zhang Kan, the second-level inspector of the Shanghai Municipal Health Commission and the director of the Science and Education Department, pointed out that the Shanghai Cord Blood Bank of China Stem Cell Group has grown out of nothing and has experienced 20 years of development. The scale of the stem cell public resource bank established is among the best in China, achieving a global goal. The success rate of Chinese matching is 100%.
What's more commendable is that China Stem Cell Group has always been committed to charity assistance and benefiting the people.
He hopes that the group can maintain its original intention, continue to develop in the field of stem cells, and repay the society.
China Stem Cell Group has always been committed to charity assistance and benefiting the people.
Photo courtesy of China Stem Cell Group
Shao Xinhua, director of the Hospital Management Office of Shanghai Jiaotong University School of Medicine, told reporters that the China Stem Cell Group Hainan Boao Stem Cell Hospital, as the Boao branch of Tongren Hospital of Shanghai Jiaotong University School of Medicine, played an important role in the “National Thalassaemia Patient Transplant Relief” major project .
The Boao Branch of Tongren Hospital actively participates in the cooperation of cross-regional medical consortia, and jointly contributes to the improvement of Hainan's medical technology.
Shanghai Jiaotong University School of Medicine will, as always, fully support the group to grow bigger and stronger in the fields of academic exchanges, talent training, and regional co-construction, so as to send the gospel to more patients with blood diseases.
In an interview, the China Stem Cell Group stated that as the national team of the stem cell industry, the group has sent two groups of party volunteer medical commandos to Wuhan and Jingzhou in this anti-epidemic operation.
The Group is willing to actively play a larger platform role, integrate various medical resources, let more advanced medical results and innovative medical concepts take root, and create a new atmosphere for the national health cause.
(Finish)